BeauBrain Healthcare

BeauBrain Healthcare is a South Korean digital health company specializing in AI-driven solutions for the early diagnosis and prevention of Alzheimer's disease and dementia. Founded by leading neurologists from Samsung Medical Center, the company provides an integrated platform that combines AI-powered brain imaging analysis, digital cognitive assessments, and digital therapeutics. Its core products include BeauBrain Amylo for PET image quantification, BeauBrain Morph for MRI-based atrophy prediction, and the SCST digital cognitive test. Through a strategic partnership with C2N Diagnostics, BeauBrain also facilitates the distribution of advanced blood-based biomarkers in the South Korean market. The company's mission is to enable precision medicine for brain health by identifying neurodegenerative biomarkers years before the onset of clinical symptoms.